Invention Grant
- Patent Title: Modified surface antigen
-
Application No.: US11933245Application Date: 2007-10-31
-
Publication No.: US08367070B2Publication Date: 2013-02-05
- Inventor: Ian Richard Anselm Peak , Michael Paul Jennings
- Applicant: Ian Richard Anselm Peak , Michael Paul Jennings
- Applicant Address: AU St. Lucia, Queensland
- Assignee: The University of Queensland
- Current Assignee: The University of Queensland
- Current Assignee Address: AU St. Lucia, Queensland
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/38 ; A61K39/02 ; A61K39/095 ; A61K31/00 ; A61K45/00 ; A61K47/00 ; C07K1/00 ; C07K14/00 ; C07K17/00

Abstract:
Novel proteins that constitute modified forms of a Neisseria meningitidis surface antigen and encoding nucleic acids are provided. The modified surface proteins are characterized by having deletions of non-conserved amino acids, and thereby being capable of eliciting cross-protective immune responses against Neisseria meningitidis. The invention extends to the use of the modified surface antigens in diagnostics, in therapeutic and prophylactic vaccines and in the design and/or screening of medicaments. The modified surface antigens are particularly useful in vaccines which effectively immunize against a broader spectrum of N. meningitidis strains than would be expected from a corresponding wild-type surface antigen.
Public/Granted literature
- US20090068216A1 MODIFIED SURFACE ANTIGEN Public/Granted day:2009-03-12
Information query